Microneedle-Assisted Transdermal Delivery of Lurasidone Nanoparticles

Microneedle-Assisted Transdermal Delivery of Lurasidone Nanoparticles

Lurasidone, an antipsychotic medication for schizophrenia, is administered daily via oral intake. Adherence is a critical challenge, given that many schizophrenia patients deny their condition, thus making alternative delivery methods desirable. This study aimed to deliver lurasidone by the transder...

Full description

Bibliographic Details
Main Authors: Ariana Radmard, Ajay K. Banga
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Pharmaceutics
Subjects:
transdermal delivery
microneedle patches
PLGA nanoparticles
controlled drug release
chemical enhancer
in vitro permeation testing
Online Access:https://www.mdpi.com/1999-4923/16/3/308

Internet

https://www.mdpi.com/1999-4923/16/3/308

Similar Items